Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Elsevier is recognized as ‘Best of Show Award Finalist’ and ‘Innovative Practices Finalist” at Bio-IT World Conference & Expo 2019

Posted on April 29th, 2019 by in Pharma R&D

Elsevier held a prominent place at last weeks Bio-IT World conference, recognized as a finalist for both ‘Best of Show’ as well as ‘People’s Choice. Highlighted was Elsevier’s Entellect, a new platform for integrated data management in pharmaceutical and life sciences industries.

(more…)

When research gives you lemons – turning R&D failures into opportunities and success

Posted on February 19th, 2019 by in Pharma R&D

As highlighted in my colleague, Nicki Catchpole’s last post on accidental drug discovery, 90 Years of Penicillin, the landscape of R&D is littered with ‘failures’ that turned out to be vital innovations. Pharmaceutical R&D is no exception.

(more…)

Games and Events: A New Era of Coopetition in Pharma R&D

Posted on December 8th, 2018 by in Pharma R&D

Although R&D competition remains as fierce as ever, many pharmaceutical companies engage in various types of cooperation and partnership ventures to help drive innovation. The goal of coopetition — when companies cooperate on certain projects while maintaining a competitive stance — is to make drug development more efficient and effective. (more…)

How Greater Collaboration and Access to Data can Help Tackle Rare Diseases

Posted on November 1st, 2018 by in Pharma R&D

It is estimated that 30 million people in the United States alone are living with one of 7,000 rare diseases, this equates to 10% of the population. There is, however, little financial incentive for the pharmaceutical sector to develop new treatments for these diseases because of the small patient population each disease affects. (more…)

  1. 1
  2. 2